Pitch deck
Atomwise
Atomwise's original pitch deck demonstrating how they accelerated drug discovery using artificial intelligence.
- Industry
- Healthcare
- Stage
- Series B
- Founded
- 2012
- Deck year
- 2020
The deck
About the company
Atomwise Inc. applies AI to pharmaceutical drug discovery, headquartered in San Francisco. It raised $174M over 4 funding rounds, with Series B at $123M to advance AI-powered drug discovery platform.
The breakdown
What Is the Atomwise Pitch Deck?
The Atomwise pitch deck presented:
AI-powered molecular structure analysis
Virtual compound screening at massive scale
Partnership model with pharmaceutical companies
Drug candidate pipeline development
Dramatically faster drug discovery timelines
Using AI to find drugs that traditional methods miss.
Why the Atomwise Pitch Deck Works The deck succeeds because it:
Demonstrates clear technical credibility
Shows pharmaceutical market access
Presents compelling time and cost savings
Key Capabilities Highlighted
Deep learning molecular analysis
Virtual screening of billions of compounds
Prediction of drug-protein interactions
Partnership with major pharma companies
Product Vision: AI That Discovers Drugs Atomwise positioned as the AI platform finding promising drug compounds faster than any traditional method.
Market Opportunity Pharmaceutical R&D spending worth hundreds of billions annually. Known inefficiencies in drug discovery process.
Business Model Research partnerships and milestone-based agreements with pharmaceutical companies. Revenue scales with successful discoveries.
Technology as Moat Proprietary AI models trained on massive molecular datasets create compounding advantages over time.
Founder insight: In biotech, partnerships validate technology. Work with established pharma early to prove value.
This Pitch Deck is taken from Best Pitch Decks
Biotech investors at SheetVenture.
Frequently asked questions
1. What exactly is Venture Sheet?
Venture Sheet is a powerful, all-in-one Google Sheet that gives you instant access to 1,000+ active investors — updated daily.
2. What drug discovery inefficiency did Atomwise's pitch deck identify?
Atomwise identified that traditional drug discovery tested compounds randomly, wasting years and billions on molecules that would inevitably fail clinically.
3. How did Atomwise's pitch deck explain AI-powered molecular screening?
The pitch showed deep learning predicting molecular interactions computationally, identifying promising drug candidates in days rather than years of laboratory work.
More decks in this space
Find the investors who fund decks like this
A deck only works in front of investors who are actually active in your stage and sector. That is the part SheetVenture answers.